Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Insights are not available.
Coherent Market Insights
Medical Nutrition Market, By Product Type (Elderly Nutrition, Parenteral Nutrition, Pediatric Nutrition, Sports Nutrition) By Application (Diabetes, Obesity, Sarcopenia, Cancer, and Others) Global Industry Insights, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Medical nutrition is the therapeutic nutritional supplements prescribed to fulfill specific nutritional needs of the patient. It is used as part of treatment of various diseases and disorders such as diabetes, Parkinson’s disease, cancer, gastrointestinal disord

Coherent Market Insights
Osteoarthritis Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Osteoarthritis also known as degenerative arthritis is the most commonly occurred chronic condition that affects joints, especially those in the knees, neck, and lower back. Osteoarthritis leads to severe joint pain and stiffness of the affected body part. These sympt

Coherent Market Insights
Muscular Dystrophy Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Muscular Dystrophy is characterized by a collection of muscle-wasting conditions. The disorder is caused by genetic mutations which interfere with the production of muscle protein dystrophin, necessary to build muscles. Muscular dystrophy is a genetic disease, consequ

Coherent Market Insights
Follicular Lymphoma Treatment Market, By Treatment Type (Radiation, Targeted Therapy, Chemotherapy And Others), By End User( Hospitals, Clinics And Speciality Centers And Cancer Research Institutes), and By Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : Mar 2018

Lymphoma refers to the cancer of lymphatic system, which affects the cells of the immune system known as lymphocytes resulting into abnormal multiplication and growth of the cells. Lymphocytes are the white blood cells that protects the body from the infection. It is

Coherent Market Insights
Lysosomal Acid Lipase (LAL) Deficiency Treatment Market, by Therapy Type (Liver Transplant and Hematopoietic Stem Cell Transplant), By Drug Type (Statins and Other Dyslipidemia Drugs and Sebelipase Alfa (Kanuma)), By Disease Indication (Wolman Disease and Cholesteryl Ester Storage Disease (CESD)), and By Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2025

To Be Published : Mar 2018

Lysosomal acid lipase (LAL) deficiency is a rare inherited condition in which the body is not able to produce enough lysosomal acid lipase (LAL) enzyme, which is an important enzyme for breakdown of fatty materials namely cholesteryl esters and tri

Coherent Market Insights
Duchenne Muscular Dystrophy (DMD) Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : Mar 2018

Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. DMD is caused due to alteration in gene sequence coding for dystrophin proterin, which is present the muscle. It is a rare muscle disease which major

Coherent Market Insights
Autoimmune Disease Treatment Market By Disease Type (Systemic and Organ Specific) and By Drug Type (Immunosuppressant’s, Anti-Inflammatory Drugs, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

According to National Institute of Health (NIH), there were approximately 23.5 million American’s suffering from an autoimmune disease in 2012. Moreover, Department of Health and Human Services, in 2017, reported that autoimmune disease (AID) is ranked first in

Coherent Market Insights
Schistosomiasis Treatment Market By Organ (Intestinal, Urogenital), By Species (Mansoni, Japonicum, Mekongi, Guineensis, Haematobium) and By Drug (Praziquantel, Metrifonate, Biltricide, Oxamniquine, Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : Mar 2018

Schistosomiasis is a disease caused by infection with freshwater parasitic worms. It can be acute or chronic infection mainly caused by parasitic worm’s blood flukes (trematode worms). There are two forms of schistosomiasis, such as intestinal and urogenital. Ac

Coherent Market Insights
Lyme Disease Treatment Market, By Disease Type (Early Lyme Disease, Lyme Carditis, Lyme Arthritis), By Treatment (Doxycycline, Amoxicillin, Cefuroxime Axetil) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : Mar 2018

Lyme disease is an infectious disease, caused due to the bacterium – Borrelia burgdorferi, which is transmitted to humans through bites of infected adult blacklegged ticks. Most human infections are caused by bites of nymphs (immature tick). Ticks can a

Coherent Market Insights
Multiple Myeloma Drugs Market By Drug Type (Immunomodulating agents, Proteasome Inhibitors, Histone Deacetylase (HDAC) Inhibitors, Corticosteroids, Monoclonal Antibodies), By Distribtuion Channel (Hospital Pharmacy, Retail Pharmacy, ePharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Multiple Myeloma is a form of cancer formed by malignant plasma cells. Malignant tumors are formed from highly unstable abnormal cells travelling via the blood stream, circulatory system, and lymphatic system. The plasma cells become cancerous and vigorously prol

Coherent Market Insights
Anxiety Disorders and Depression Treatments Market By Drug Class (SRis, SNRis, TeCAs, TCSs and others), and By Distribution Channel (Pharmacy stores, and E-commerce) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

The anxiety and depression are known to be the most common forms of psychiatric disorders from which a large population is affected across the globe. . Depression is the most common type of mental disorder encountered in the global population, while anxiety refers to

Coherent Market Insights
Equine Healthcare Market, By Diagnostic Products (Pregnancy and Gestation Diagnostic, Genotyping Analysis), Therapeutic Products (Dopamine Agonists, Vaccines, Anti-Bacterial, Anti-Protozoal, Anti-Viral, Laxatives, Anti-Inflammatory), and Supplements (Performance and Protection Supplements) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Equine Healthcare refers to the activities and practices aimed for the maintenance of horses.  Equine healthcare offers the veterinary services intended for treating horses to enhance their quality of life, develop quality animal food and increase lifespan. The t

Coherent Market Insights
Ambulatory Services Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Ambulatory care refers to the medical services provided on an outpatient basis without hospitalization or other medical facility. Outpatient services include physician and dentist offices, medical laboratories, and home healthcare. Ambulatory care service is one of th

Coherent Market Insights
Batten Disease Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Batten disease is a rare, inherent, and fatal autosomal recessive neural disorder that begins in the childhood but may take a few years to show symptoms. Batten disease is one of the approximately 50 diseases that fall under the category of lysosome shortage disorders

Coherent Market Insights
Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Attention deficit hyperactivity disorder (ADHD) is a neural disorder. The disorder is characterized by impulsiveness, hyperactivity, and attention difficulty. Treatment of ADHD involves a combination of counseling, medications, and lifestyle changes. ADHD is the

Coherent Market Insights
Novel Drug Delivery System (NDDS) Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Novel Drug Delivery System (NDDS) refers to the formulations, systems to transport pharmaceutical compound in the body, and approaches needed to achieve the desired therapeutic effect. The side effects and slow processing of conventional drug therapy are contributing

Coherent Market Insights
Nursing Care Services Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Nursing care services provide special care to patients suffering from chronic diseases such as Parkinson’s disease, Alzheimer’s disease, patients who need care for injury, and who are ill and require continuous attendance. At the nursing care services cent

Coherent Market Insights
Small Cell Lung Cancer Therapeutics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Small Cell Lung Cancer (SCLC) is malignant form of cancer arising within the lungs. SCLC is characterized by high growth rate, shorter doubling time than the non-small cell lung tumors. SCLC is more responsive to chemotherapy than NSCLC. Small cell lung cancer is high

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.